Biohybrid M13 phage backpacks for active blood–brain barrier traversal and precision central nervous system leukemia treatment

Wei Wu, Cheng-Ling Zhang, Yu-Ling Yang, Xiaoyuan Chen, Xi Zhang, Xue Dong · 2026

Read Biohybrid M13 phage backpacks for active blood–brain barrier traversal and precision central nervous system leukemia treatment by Wei Wu, Cheng-Ling Zhang, Yu-Ling Yang, Xiaoyuan Chen, Xi Zhang, Xue Dong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13579763.txt.

Description

Wei Wu and co-authors built a virus based carrier in 2026 to smuggle a leukemia drug across the blood brain barrier. Leukemia in the brain is hard to treat because that barrier blocks most drugs, leading to relapse and poor outcomes.

Their carrier uses a long, thin bacterial virus fitted with guides that home to the barrier and cross it. Riding on it is a backpack: a fatty packet wrapped in leukemia cell membrane, loaded with a standard drug, so it homes to leukemia cells. A linker that snaps only in spinal fluid releases the packet. In cell and mouse tests, the system crossed the barrier, killed leukemia cells, and stretched survival from twenty-nine to forty days.

Catalog record

CREATORWei Wu, Cheng-Ling Zhang, Yu-Ling Yang, Xiaoyuan Chen, Xi Zhang, Xue Dong
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13579763

Browse the full library · About the Tower of Babel